Springhill Fund Asset Management’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
– Sell
-2,173
Closed -$339K – 3
2025
Q1
$339K Buy
+2,173
New +$310K 1.62% 15

Other funds holding ASND

Springhill Fund Asset Management's ASND Position: Q2 2025 in Review

Springhill Fund Asset Management sold out of Ascendis Pharma (ASND) in Q2 2025, closing a stake of 2,173 shares — an estimated $339K sold.

Springhill Fund Asset Management first reported a position in ASND in Q1 2025 and held it in 1 quarter. The position peaked at $339K in Q1 2025. 248 funds tracked by Wall St. Rank hold ASND as of Q2 2025.

  • Springhill Fund Asset Management reported no remaining Ascendis Pharma position as of Q2 2025 after selling out during the quarter.
  • Springhill Fund Asset Management sold 2,173 Ascendis Pharma shares in Q2 2025, an estimated $339K.
  • Springhill Fund Asset Management first reported a position in Ascendis Pharma in Q1 2025 and held it in 1 quarter.
  • Springhill Fund Asset Management's Ascendis Pharma position peaked at $339K in Q1 2025.
  • 248 funds tracked by Wall St. Rank held Ascendis Pharma as of Q2 2025.

Based on Springhill Fund Asset Management's 13F filing for Q2 2025.